Absci Corporation (ABSI)
NASDAQ: ABSI
· Real-Time Price · USD
3.02
0.18 (6.34%)
At close: Jun 06, 2025, 3:59 PM
3.09
2.15%
Pre-market: Jun 09, 2025, 09:11 AM EDT
6.34% (1D)
| Bid | 3.08 |
| Market Cap | 385.87M |
| Revenue (ttm) | 3.64M |
| Net Income (ttm) | -107.48M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -3.25 |
| Forward PE | -4.1 |
| Analyst | Buy |
| Ask | 3.09 |
| Volume | 3,111,501 |
| Avg. Volume (20D) | 3,079,014 |
| Open | 2.88 |
| Previous Close | 2.84 |
| Day's Range | 2.87 - 3.07 |
| 52-Week Range | 2.01 - 6.33 |
| Beta | 2.07 |
About ABSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-1.69%
ABSI stock has given up its prior gain. Absci shar...
Unlock content with
Pro Subscription
3 weeks ago
-1.69%
Absci shares are trading higher after the company announced it began dosing the first participants in its Phase 1 ABS-101 clinical trial.
2 months ago · seekingalpha.com
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous MarketAbsci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Despite weak financials, Absci's internal pipeline, including ABS-101 and ABS-201, offe...
